Cuál es el precio por Shanghai MicroPort MedBot (Group) Co., Ltd. (2252)

Precio por Shanghai MicroPort MedBot (Group) Co., Ltd. (2252) es de$2.91

Cuál es la capitalización de mercado por Shanghai MicroPort MedBot (Group) Co., Ltd. (2252)

Capitalización de mercado por Shanghai MicroPort MedBot (Group) Co., Ltd. (2252) es $2.98B

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252) Rendimiento por Dividendo

Shanghai MicroPort MedBot (Group) Co., Ltd. focuses on the comprehensive research, development, design, production, and distribution of surgical robotic systems, catering to markets in China and Europe. Their innovative product range features Toumai, a versatile laparoscopic surgical robot employed in urologic, gynecologic, thoracic, and general surgeries. They also provide DFVision, a 3D electronic laparoscope designed to improve visualization during abdominal, thoracic, and pelvic operations. For orthopedic procedures, the Honghu robot aids in knee and hip joint replacements, while the R-One system is specifically engineered for vascular interventions like coronary angioplasty. The iSR'obot, known as the Mona Lisa robotic system, specializes in transperineal prostate biopsies. Additionally, the company's offerings extend to specialized robots for spinal procedures, trans-bronchial diagnosis and treatment, TAVR (Transcatheter Aortic Valve Replacement), and automated needle-targeting systems for precise percutaneous lung biopsies and nephrolithotomy. Founded in 2014 and headquartered in Shanghai, China, the company functions as a subsidiary of MicroPort Scientific Corporation.

Año	Rendimiento por dividendo	Cambiar
Not enough data for the provided dates.

Año

Rendimiento por dividendo

Cambiar

Not enough data for the provided dates.

Empresa	Rendimiento por dividendo	País
Abbott Laboratories ABT.US	2.23%	US
Stryker Corporation SYK.US	1.03%	US
Medtronic plc MDT.US	3.69%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

Empresa

Rendimiento por dividendo

País